SLXN
$1.22-0.22 (-15.21%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.22
Potential Upside
5%
Whystock Fair Value$1.28
Price
UndervaluedFair ValueOvervalued
Fundamentals
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its propriet...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-132.54%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.97
